13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 41 holding rows worth $364,337,000.
- Accession
- 0001826434-22-000008
- Filer
- CIK 1826434
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 41 entries on the cover page, a total value of $364,337,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $364,337,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 105,170 | $34,007,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 90,551 | $24,177,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 64,152 | $22,649,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 196,390 | $20,859,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 30,115 | $20,745,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 235,320 | $17,028,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 285,948 | $15,393,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 106,528 | $14,199,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 171,082 | $14,137,000 | thousands by filing date | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 771,933 | $13,077,000 | thousands by filing date | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 289,300 | $12,099,000 | thousands by filing date | call |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 409,503 | $12,052,000 | thousands by filing date | |
| BAUSCH PLUS LOMB CORP | 071705107 | COMMON SHARES | 700,525 | $10,746,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 151,534 | $10,583,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 95,445 | $10,550,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 825,109 | $9,728,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 784,133 | $8,469,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 123,599 | $7,294,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 280,811 | $7,169,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 209,248 | $7,125,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 238,569 | $6,706,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 636,943 | $6,121,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 709,733 | $6,111,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 631,579 | $5,709,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 129,955 | $5,695,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 683,613 | $5,517,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 134,331 | $4,849,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 125,000 | $4,364,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 2,504,006 | $4,282,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 23,412 | $4,153,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 190,597 | $3,419,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 53,754 | $2,561,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 36,460 | $2,383,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 214,661 | $2,267,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 157,303 | $2,009,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 79,411 | $1,906,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 199,500 | $1,682,000 | thousands by filing date | call |
| FIBROGEN INC | 31572Q808 | COM | 74,348 | $967,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 42,826 | $804,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 711,798 | $626,000 | thousands by filing date | |
| FEMASYS INC | 31447E105 | cs | 106,606 | $120,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-22-000008 | this filing | 2022-11-14 | acceptance time not in the bulk data set |